Alteration in the serum concentrations of FGF19, FGFR4 and βKlotho in patients with thyroid cancer

Our results indicate that a disrupted FGF19/FGFR4/βKL signaling pathway may play a role in the development of thyroid cancers. However, further studies are needed to elucidate the molecular mechanism of the neoplastic transition of thyroid epithelial cells.